Latest news
Here's What Analysts Are Forecasting For Eris Lifesciences Limited (NSE:ERIS) After Its First-Quarter Results - webull.comwebull.com · Tue, 04 Aug 2026 13:47:46 GMTKitchen Table Kibitzing 7/29/26: Eris - Daily KosDaily Kos · Thu, 30 Jul 2026 00:30:00 GMTEris Life to add insulin aspart this calendar; sees semaglutide uptake improving on weight-loss tag - ET PharmaET Pharma · Wed, 29 Jul 2026 17:25:25 GMTERIS: Q1 revenue up 13% and profit after tax up 14%, with margin recovery expected as new capacity ramps - TradingViewTradingView · Wed, 29 Jul 2026 14:24:14 GMTEris Lifesciences Q1 PAT rises 14.5% on strong domestic formulations growth; insulin, GLP-1 businesses shine - TradingViewTradingView · Wed, 29 Jul 2026 11:15:52 GMTEris Lifesciences Ltd (NSE:ERIS) Q1 2027 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT